MSI1 and neoplasm: Several studies have shown the potential therapeutic target of MSI1 given that when MSI1 is knockdown tumor growth is delayed as well as cell proliferation, migration, and invasion (Sureban et al., 2008; Gao et al., 2015; Smith, 2015; Kharas and Lengner, 2017).